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Acute kidney injury (AKI) is an increasingly encountered 
clinical situation in the intensive care setting. In this 
context in addition to sepsis, cardiac surgery-associated 
AKI (CSA-AKI) is one of the most common causes of 
acute renal failure (1). Depending on the definition of AKI 
and preexisting risk factors, the incidence CSA-AKI varies 
between 3% and 40% of patients undergoing open heart as 
well as transcatheter aortic valve implantation (1,2). Several 
diagnostic systems have defined AKI according to similar 
criteria of kidney function (3,4). The last consensus criteria 
have been proposed by Kidney Disease Improving Global 
Outcomes (KDIGO) Acute Kidney Injury Work Group (5). 
KDIGO criteria for diagnosis and staging reuse the Acute 
Kidney Injury Network (AKIN) system (4) with minor 
modifications. According to KDIGO, a broad definition 
of AKI includes one of the following observations: (I) 
an increase in serum creatinine (SCr) by ≥0.3 mg/dL 
(≥26.5 µmol/L) within 48 h, or (II) an increase in SCr to 
≥1.5 times baseline within the previous 7 days, or (III) urine 
volume ≥0.5 mL/kg/h for 6 h (6). Although a relatively 
high proportion of patients undergoing open heart surgery 
develop postoperative minor forms of CSA-AKI, only 
1% of these patients present a severe AKI necessitating 
renal replacement therapy (RRT) (7). Severe CSA-AKI is 
associated with increased perioperative mortality, prolonged 
length of stay in the intensive care unit (ICU) and in 
hospital, and increased cost of care (8). The risk of death 
and hospital readmissions associated with AKI remains high 
even 5 to 10 years after cardiac surgery regardless of other 
risk factors, even for those patients with complete renal 
recovery (7).
The pathogenesis  of  CSA-AKI is  complex and 
multifactorial. Several pre-, intra- and post-operative 
factors may negatively affect the development of CSA-
AKI. Predisposing factors such as age, chronic kidney 
disease, diabetes, arterial hypertension and atherosclerosis, 
intra-operative characteristics including the type of 
cardiac surgery, surgical time and cardiopulmonary 
bypass (CPB) technique and management (9), as well as 
postoperative mishaps like hemodynamic instability, use of 
nephrotoxic drugs or anemia may also contribute to CSA-
AKI (8). Besides, CBP per se by activating the release of 
inflammatory mediators and by inducing hemodilution 
can favor the occurrence of AKI, especially in patients 
presenting with predisposing factors (9). The prompt 
diagnosis of AKI at its initial stage after cardiac surgery is 
not easy to establish. However, early detection of CSA-AKI 
can help limiting renal injury by establishing appropriate 
corrective therapies of reversible factors that contribute 
to AKI and thus improving patient prognosis. For early 
detection of CSA-AKI, based on their previous reports (4), 
the Cleveland group introduced new and expanded 
predictive models  using pre- and intra-operative 
variables (10). In their study, 18 pre-operative and 4 intra-
operative characteristics were included in four models of 
either pre-operative data alone or combined pre- and intra-
operative data to predict either single primary endpoint of 
dialysis therapy or composite primary endpoint of dialysis 
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therapy or doubling of SCr (10). Interestingly, in the 
studied population the 2 models predictive of the dialysis 
therapy endpoint using presurgical only or pre- and intra-
surgical combined variables showed excellent discrimination 
and good calibration, whereas the 2 models predictive of 
the composite endpoint (doubling of SCr level or dialysis 
therapy) showed good discrimination, but suboptimal 
calibration (10). These predictive models developed in 
a US population could not be externally validated in a 
European population (11). The two predictive models for 
single primary endpoint of dialysis therapy (pre-operative 
data alone or combined pre- and intra-operative data) 
demonstrated only a good discriminative capacity (11). In 
contrast to the report of Demirjian (10), the two models 
(pre-operative data alone or combined pre- and intra-
operative data) predicting the composite endpoint of either 
dialysis therapy or a doubling of SCr level showed fair 
discriminative capacity (11). Moreover, a lack of calibration 
was observed not only in the two predictive models for 
single primary endpoint of dialysis therapy but also in those 
predicting the composite endpoint of either dialysis therapy 
or a doubling of SCr level (11). These discrepancies between 
the studies are mainly due to the inevitable differences in 
patients’ characteristics and changes in medical technology 
and standards of care over time. Therefore, recalibration by 
readjustment to local patients’ characteristics and structural 
model revisions by adding new variables might be necessary 
to enhance the applicability of the predictive models. 
Along these lines, several investigators have focused 
on the identification of biomarkers beyond SCr for early 
detection of AKI. This interest is motivated by the fact that 
a significant rise in SCr marks an already advanced stage 
of kidney injury. Moreover, in elderly and malnourished 
patients the rise in SCr might be minimal and considerably 
delayed. Another reason for searching other biomarkers 
of AKI is the distinction made between “renal failure” and 
“renal injury”. In fact, renal injury may have various clinical 
consequences without significant deterioration of renal 
function (12). Ideal biomarkers may be expected to fulfill 
simple criteria: (I) rapid, inexpensive, and noninvasive or 
minimally invasive measurement technique; (II) sensitive 
to establish an early and specific diagnosis but remaining 
elevated for a long time to allow diagnosis; (III) specific 
cutoff values, with an increase that is proportional to 
the degree of damage and a high gradient to allow risk 
stratification; (IV)associated with a known biological 
mechanism (plausibility); (V) capability to predict clinical 
outcomes and therapy response (12). These considerations 
imply that a combination of biomarkers rather than a single 
pathognomonic one may be necessary for early detection 
of AKI. Numerous biomarkers have been reported to allow 
the diagnosis of AKI at its early stages. These biomarkers 
are of biochemical or biomechanical nature. 
B i o c h e m i c a l  m a r k e r s  i n c l u d e  n e u t r o p h i l 
gelatinase-associated lipocalin (NGAL), cystatin C (CysC), 
kidney injury molecule-1 (KIM-1), monocyte chemotactic 
peptide-1 (MCP-1), N-acetyl-β-D-glucosaminidase 
(NAG), interleukin-18 (IL-18), liver-type fatty acid-binding 
protein (L-FABP), netrin-1, cycle arrest biomarkers such 
as insulin-like growth factor binding protein 7 (IGFBP7) 
and tissue inhibitor of metalloproteinases-2 (TIMP-2), 
endogenous ouabain (EO), selenium-binding protein 1 
(SBP1) and BPIFA2 salivary protein (13). The majority of 
these biochemical markers are detected in urine. Compared 
to blood harvest for measurement of biomarkers urine 
harvest is noninvasive, accompanied by a reduced number 
of interfering proteins with an increased specificity for 
renal injury. In contrast to serum measurements, they 
have the disadvantages of the lack of samples from anuric 
patients, and the changes in the biomarker concentrations 
depending on the hydration status and diuretic therapy. 
Serum biomarkers avoid some of the urinary biomarker 
disadvantages. Nevertheless, their concentration can 
be modified by secretion from nonrenal sources and by 
subclinical changes in renal excretion (13). 
Despite recent advances in characterization of new 
AKI biochemical markers, a few uncertainties limit their 
widespread clinical use: the timing for the measurement 
of AKI biochemical markers is not yet fully established; 
the significance of their increase can be mitigated by other 
clinical conditions such as an inflammatory status; the 
kinetics of their rise in different subset of patients including 
different ages groups is not sufficiently investigated; their 
expression profile may be different between various clinical 
settings such as CSA-AKI and sepsis-associated AKI. At 
present time, these limitations do not allow to justify the 
cost of these analyses in routine practice (14).
Beside biochemical markers of AKI, renal resistive index 
(RRI) is the most frequently measured biomechanical marker 
for detection of AKI at its early stage. The noninvasive 
assessment of RRI is performed by transparietal echography 
(TPE) or transesophageal echocardiography (TEE) during 
cardiac surgery by analyzing the intrarenal arterial Doppler 
waveform. It is derived from Doppler flow velocities as 
(maximal systolic velocity–minimum diastolic velocity)/
maximal systolic velocity. Its value in general population 
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averages 0.6 and increases with age, female sex and body 
weight or body mass index but has an inverse relationship 
with body height (15). Several other factors affect the RRI 
value: (I) systemic hemodynamics directly influence RRI 
which increases with increasing pulse pressure and systolic 
or decreasing diastolic blood pressure as well as with 
reduced heart rate (15). In parallel to the latter condition, 
the use of beta-blockers induces a rise in RRI (15). In 
addition to blood pressure characteristics, total circulating 
blood volume and hence fluid management and cardiac 
output have been reported to inversely act on RRI (16); 
(II) Diabetes mellitus and atherosclerosis negatively impact 
the elasticity of the large as well as small vessel walls and 
thus are associated with increased RRI values in affected 
patients as compared to normal subjects (17,18).
Another biomechanical marker of AKI is represented by 
measurement of renal real-time regional oximetry by near-
infrared spectroscopy. This technique has been reported in 
newborns undergoing cardiac surgery for congenital heart 
disease. The sensors were placed on the back of the babies 
at the level of T10–T12 left and right of the spine (19). 
However, because of the importance of the skin-kidney 
distance in in infants and adults this technique has been so 
far used only in neonates younger than 12 months weighing 
less than 10 kg (19). In future, technological advances may 
make this method available in adults.
Given the noninvasiveness, relatively low cost and 
availability of RRI measurements compared to biochemical 
biomarkers determinations in the setting of cardiac surgery, 
several investigators have studied the value of RRI in 
predicting CSA-AKI (20-23). In a prospective observational 
study, Bossard and co-workers found in multivariate 
analysis a significant correlation between increased 
postoperative RRI upon arrival in the intensive care unit 
and the occurrence of postoperative AKI according to 
the RIFLE definition (20). They concluded that on the 
receiver operating characteristic (ROC) curve a value of 
RRI >0.74 allowed with a good sensitivity and specificity 
to predict CSA-AKI. The conclusion of this study 
should be considered with caution. The selection criteria 
included a series of known risk factors for development 
of AKI. Besides, pre-operative RRI was measured only in 
a small number of patients. Thus, pre-existing increased 
RRI could not be excluded. Interestingly, the incidence 
of AKI was similar between the studied group with risk 
factors for development of AKI and the entire patient 
population undergoing cardiac surgery during the same 
period (20). This raises the question of pertinence of 
their selection criteria of risk factors for development of 
AKI. In another study, Guinot et al. reported a value of 
RRI >0.73 on the ROC curve to be predictive of CSA-
AKI (21). The weaknesses of this study lie on the small 
number of investigated patients and the definition of AKI 
which was based on the sole increase of SCr levels. In a 
more recent study, Regolisti and collaborators observed a 
limited ability of intrarenal RRI measured by either TPE 
or TEE to predict CSA-AKI (22). On the ROC curve for 
RRI by either technique the AUC was 0.7–0.71. Moreover, 
combining RRI with serum NGAL at end-surgery did 
not provide a clear-cut advantage in predicting AKI (22). 
Comparable drawbacks of this study to the previous ones, i.e. 
small number of patients and the definition of AKI based 
on the sole increase of SCr levels, limit the relevancy of the 
conclusions. Using AKIN criteria for definition of AKI in 
a prospective observational study of patients undergoing 
cardiac surgery, Hertzberg et al. reported a weak predictive 
value for developing AKI according to an increased RRI 
>0.7 with a sensitivity of 0.78 and a specificity of 0.46 (23). 
Again, the small number of patients of this study renders its 
conclusion of limited applicability.
In a recent paper, Andrew and coworkers retrospectively 
studied the impact of aortic valve pathology on the 
preoperative RRI in an adult patient population undergoing 
cardiac surgery (24). An interesting finding of this study 
was that pre-operative aortic valve insufficiency per se was 
not associated with a higher incidence of AKI following 
corrective surgery. Moreover, they found that patients with 
aortic insufficiency and combined insufficiency/stenosis 
had higher median preoperative RRI values compared 
with patients without aortic valve pathology. Based on 
their findings, they cautioned about the potentially 
confounding effects of aortic insufficiency on renal flow 
patterns, independent of renal injury. Consequently, they 
recommended that pre-existing moderate to severe aortic 
valve insufficiency should be taken into account when using 
pre-operative RRI to predict post-operative AKI (24). The 
finding of Andrew and coworkers confirm earlier concerns 
that RRI might not accurately reflect renal resistance 
and renal blood flow in the presence of aortic valvular 
insufficiency (25). In this case, the renal artery diastolic 
velocity will be nearly 0. Thus, the RRI [(maximal systolic 
velocity–minimum diastolic velocity)/maximal systolic 
velocity] will be approximately 1, suggesting that renal 
blood flow has a very high resistance, leading possibly to 
an erroneous conclusion of possible renal dysfunction (25). 
Thus, in the presence of significant aortic insufficiency, 
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RRI might not accurately reflect renal flow resistance, 
resulting in an inaccurate impression of reduced renal blood 
flow from increased renal vascular resistance (25). The 
weaknesses of the Andrew’s study lie on its retrospective 
character with small numbers. In contrast to the existing 
evidence (15), Andrew and coworkers did not find any 
correlation between age and gender and RRI (24). Another 
limitation to their study is the lack of information on 
pre-operative medication of the patients, particularly on 
diuretics and beta-blockers.
In summary, severe CSA-AKI is associated with increased 
perioperative mortality, prolonged length of stay in the 
ICU and in hospital, and increased cost of care following 
cardiac surgery. The risk of death and hospital readmissions 
associated with CSA-AKI remains high even 5 to 10 years 
after cardiac surgery regardless of other risk factors, even 
for those patients with complete renal recovery. Predictive 
risk models combining biochemical markers of AKI and 
RRI may allow early detection of AKI and thus prompt 
adaptation of therapeutic strategies to limit AKI and to 
improve prognosis. However, well-designed prospective 
randomized trials with adequate statistical power are still 
needed to address the value of each biomarker of AKI to be 
included in such a predictive model.
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